November 19th 2021
The Food and Drug Administration (FDA) has authorized Pfizer and Moderna’s coronavirus booster vaccines for all all adults, which will make the shots available to all Americans ages 18 and over.
Friday morning’s announcement by the FDA expanded emergency use authorization for the booster of both mRNA vaccines.
‘The FDA has determined that the currently available data support expanding the eligibility of a single booster dose of the Moderna and Pfizer-BioNTech Covid-19 vaccines to individuals 18 years of age and older,’ stated Dr Peter Marks, who is director of the FDA’s Center for Biologics Evaluation and Research.
Previously, boosters had been cleared for people 65 years and older who were vaccinated with Pfizer or Moderna jabs at least six months ago and for adults at high risk of severe disease.
Pfizer had requested authorization for its booster last week, submitting results of a Phase 3 trial with more than 10,000 participants. The trial found the booster to be safe and 9i5% effective against symptomatic coronavirus, versus taking the first two vaccine doses when the highly transmissible Delta variant was the dominant strain.
Meanwhile, Moderna requested authorization on Wednesday.
Breaking story, check back for updates…